Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hepatic function abnormal
ADR ID BADD_A02005
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.02      Hepatic enzymes and function abnormalities
09.01.02.001      Hepatic function abnormal
Description Not Available
MedDRA Code 10019670
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute derangement of liver function | Dysfunction hepatic nonicteric | Function liver abnormal | Function liver decreased | Hepatic dysfunction allergic | Hepatic dysfunction nonicteric | Hepatic dysfunction NOS | Hepatic dysfunction transient | Hepatic function abnormal | Hepatic function abnormal NOS | Hepatic function aggravated | Hepatic function decreased | Hepatic function disorder | Impaired liver function | Hepatic function abnormal aggr. | Hepatic impairment | Hepatic dysfunction non-icteric | Dysfunction hepatic non-icteric | Hypohepatia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01127Idarubicin--
BADD_D01133Ifosfamide--
BADD_D01141Imipramine pamoate--
BADD_D01142Imiquimod--
BADD_D01143Immune globulin--
BADD_D01144Immunoglobulin (human)--
BADD_D01145Immunoglobulin g (human)--
BADD_D01151Indinavir sulfate--
BADD_D01156Indomethacin--
BADD_D01167Interferon alfa-2b--
BADD_D01168Interferon alfacon-1--
BADD_D01194Irbesartan--
BADD_D01203Isoflurane--
BADD_D01204Isoniazid0.036693%
BADD_D01213Isotretinoin--
BADD_D01217Itraconazole0.031266%
BADD_D01220Ivacaftor-
BADD_D01228Ketamine0.000357%
BADD_D01230Ketoconazole0.000132%
BADD_D01231Ketoprofen--
BADD_D01238Lacosamide0.004388%
BADD_D01241Lamisil--
BADD_D01242Lamivudine0.009107%
BADD_D01243Lamotrigine0.001766%
BADD_D01245Lansoprazole0.000617%
BADD_D01248Lapatinib0.000168%
BADD_D01251Latanoprost--
BADD_D01252Leflunomide--
BADD_D01254Lenvatinib0.005652%
BADD_D01257Letrozole0.001054%
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target